AFP and hepatocellular carcinoma: It appeared that the performance of mSEPT9, AFP and PIVKA-II was not affected by the etiology of HCC, as no significant difference in sensitivity was found among HBV, HCV, alcoholic and others groups (Supplementary Table 1).